CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
intra-procedural intracardiac echocardiography (ICE) probedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05136417
NCT05136417N/ACompleted

Safety and Feasibility of Intra-Cardiac Echocardiography in Guiding Left Atrial Appendage Occlusion With the Watchman Device: The ICE WATCHMAN Study

Mayo Clinic·interventional·Posted Nov 29, 2021·Updated Dec 27, 2024

In Brief

A clinical study evaluating intra-procedural intracardiac echocardiography (ICE) probe for Left Atrial Appendage Occlusion. Completed, enrolled 100 participants across 2 sites.

Detailed Summary

The purpose of this research is to to assess the feasibility and safety of left atrial appendage (LAA) occlusion with the WATCHMAN FLX™ device using a standardized intra-procedural intracardiac echocardiography (ICE) protocol under moderate sedation for procedural guidance.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedNov 29, 2021
Enrollment StartJan 4, 2022
Primary CompletionDec 15, 2023
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 4.6 years ago

Interventions

intra-procedural intracardiac echocardiography (ICE) probedevice

placing the WATCHMAN FLX device using the intra-procedural intracardiac echocardiography (ICE) probe.